Skip to main content

Table 1 Baseline clinical characteristics and angiographic and procedural characteristics

From: New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins

Variables Atorvastatin (n = 1349) Rosuvastatin (n = 872) P-value
Men 1105 (81.9%) 720 (82.6%) 0.693
Age (years) 61.0 ± 12.5 61.0 ± 12.6 0.918
LV ejection fraction (%) 54.1 ± 9.9 54.0 ± 9.6 0.906
Body mass index (kg/m2) 24.5 ± 3.2 24.4 ± 3.4 0.442
Myocardial infarction
 ST-segment elevation 719 (53.3%) 478 (54.8%) 0.483
 Non-ST-segment elevation 630 (46.7%) 394 (45.2%)  
Hypertension 549 (40.7%) 329 (37.7%) 0.162
Cerebrovascular accidents 42 (3.1%) 29 (3.3%) 0.781
Total cholesterol (mg/dl) 195.5 ± 42.0 196.6 ± 45.6 0.563
Triglyceride (mg/dl) 146.5 ± 120.3 145.4 ± 139.1 0.852
HDL-cholesterol (mg/dl) 44.1 ± 11.1 44.0 ± 11.1 0.790
LDL-cholesterol (mg/dl) 126.5 ± 36.3 130.6 ± 40.3 0.020
CK-MB (mg/dl) 125.2 ± 159.2 139.9 ± 145.1 0.029
Glucose (mg/dl) 136.7 ± 37.4 138.8 ± 37.9 0.216
Creatinine (mg/dl) 0.97 ± 0.94 0.94 ± 0.42 0.340
Discharge medications
 Aspirin 1343 (99.6%) 865 (99.2%) 0.280
 Clopidogrel 855 (63.4%) 473 (54.2%) < 0.001
 Prasugrel 188 (13.9%) 68 (7.8%) < 0.001
 Ticagrelor 302 (22.4%) 325 (37.3%) < 0.001
 Cilostazol 57 (4.2%) 29 (3.3%) 0.283
 Calcium channel blockers 63 (4.7%) 45 (5.2%) 0.600
 β blockers 1181 (87.5%) 714 (81.9%) < 0.001
 ACEi 687 (50.9%) 321 (36.8%) < 0.001
 ARB 426 (31.6%) 336 (38.5%) 0.001
Procedural characteristics
 Total stent length (mm) 27.6 ± 12.2 39.8 ± 13.4 < 0.001
 Total stent number 1.17 ± 0.41 1.20 ± 0.45 0.077
 Stent diameter (mm) 3.20 ± 0.44 3.14 ± 0.44 0.062
  1. ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CK-MB Creatine Kinase-MB, HDL high-density lipoprotein, LDL low-density lipoprotein, LV left ventricle